期刊文献+

人绒毛膜促性腺激素治疗先兆流产有效性的meta分析 被引量:2

Meta-analysis of the efficacy of human chorionic gonadotrophin for threatened miscarriage
原文传递
导出
摘要 目的:系统评价人绒毛膜促性腺激素治疗先兆流产的有效性。方法:检索2018年2月前,发表于万方医学、中国知网、维普医学、中国生物医学、Medline、Embase、Cochrane和Clinical trails数据库的人绒毛膜促性腺激素治疗先兆流产的随机对照研究。纳入符合筛选标准的文献,对文献进行质量评价,提取数据后进行meta分析。结果:与安慰剂组(22.32%)相比,人绒毛膜促性腺激素治疗组流产率(11.00%)降低(MD=0.48,95%CI:0.30~0.76),Z=3.15(P=0.002)。纳入的英文文献中无不良反应报道,中文文献中发现用药组新生儿体重略高于对照组,且观测到2例先天性多囊肾的新生儿。归纳h CG相关文献,还有存在应用后出现注射局部红肿和肝酶一过性升高等轻度不良反应,以及卵巢过度刺激综合征、水肿和血栓等中重度不良反应的个案报道。结论:人绒毛膜促性腺激素在治疗先兆流产中疗效显著,但结合文献质量评价和不良反应报道,该药物应在严密监控下谨慎使用。 Objective: To systematically review the efficacy of human chorionic gonadotropin in the treatment of threatened abortion.Methods: Wanfang data, China National Knowledge Internet, VIP medical, China Biology Medicine disc, Medline, Embase, Cochrane and Clinical trials database were searched systematically for randomized controlled trials of human chorionic gonadotropin(h CG) in the treatment of threatened abortion published before February 2018. We selected the articles that accorded with all eligibility criteria and assessed the quality of the included studies. Rev Man 5.3 was used to perform meta-analysis after data extraction. Results: Compared with the abortion rate in the placebo group(22.32%), that in the h CG treatment group(11.00%) was reduced(MD=0.48, 95%CI:0.30-0.76, Z=3.15, P=0.002). No English trials reported any adverse effects of h CG on the mothers or fetuses. In the Chinese trials, the neonatal weight of the HCG group was slightly higher than that of the control group, and two newborns had congenital polycystic kidney disease. In the h CG related literature, some mild adverse reactions were reported such as local injection swelling and transient increase of liver enzymes, and there were also case reports of ovarian hyperstimulation syndrome, edema, and thrombosis. Conclusion: Human chorionic gonadotropin is effective for the treatment of threatened abortion. However, considering the literature quality and adverse reaction reports, the drug should be used with caution under monitoring.
作者 王安妮 冯欣 WANG An-ni;FENG Xin(Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China;Department of Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China)
出处 《临床药物治疗杂志》 2018年第3期10-13,共4页 Clinical Medication Journal
关键词 人绒毛膜促性腺激素 HCG 先兆流产 META分析 human chofionic gonadotropin hCG threatened miscarriage meta-analysis
  • 相关文献

参考文献3

二级参考文献27

  • 1余传鑫.实用妇科内分泌[M].上海:上海医科大学出版社,2003:217.
  • 2Gruber CJ,Huber JC.The role of dydrogesterone in-recuirent(habitual) abonion[J] J Steriod Biochem Mol Biol,2005,97(5):426-430.
  • 3Kelemen K,Bognar I,Pa AL M,et al.A progesterone-in-duced protein increases the synthesis of asymmetric antibodies[J].Cell Immunol,2006,167(1):129-134.
  • 4Omar MH,Mashita MK,Lin PS,et al.Dv[trogesteronE:in threatened aborion:pregnancy outcome[J].J Steroid BiochemMol Biol,2005,97(5):421-425.
  • 5El Zibdeh MY.Dydrogesterone in the reduction Of recurrent spontaneous abonion[J].J Steroid Biochem Mol Biol,2005,97(5):431-434.
  • 6Harrison RF.A comparative study of human chorionic gonadotropin,placebo,and bed rest for women with early threatened abortion[J].Int J Fenil Menopa-usal Stud,2003,38(3):160-165.
  • 7Parant O,Maillard F,Tsatsaris V, etal. Management of threat- ened preterm delivery in France: a national practice survey (the EVAPRIMA study)[J]. British Journal of Obstetrics and Gy- naecology, 2008,115(12) : 1538-1546.
  • 8Kalinka J, Szekeres Bartho J. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abor- tion[J]. American Journal of Reproductive Immunology, 2005, 53(4):166-171.
  • 9Ornar MH, Mashita MK, Lin PS, et al. Dydrogesterone in threatened abortion:pregnancy outcome[J]. J Steroid Biochem Mol Bi01,2005,97(5) :421-425.
  • 10E1 Zibdeh MY. Dydrogesterone in the reduction Of recurrent spontaneous abonion[J]. J Steroid Biochem Mol Biol, 2005,97 (5) :431-434.

共引文献314

同被引文献25

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部